King County Navigation Bar (text navigation at bottom)
Public Health - Seattle & King County
Site Directory

Public Health Webpage Directory

Public Health Center & Office Locations
For Care Providers

Health Advisories & Resources
For Educators

Health Educators Toolbox
About Us

History & Profile

Jobs

Employee Directory

Contact HIV/AIDS

Info on HIV/AIDS:

206-205-7837
TTY: 206-296-4843
Toll-free: 800-678-1595

Administration:

206-296-4649

HIV/STD Testing

HIV/STD Hotline:

206-205-7837 or
Toll-free: 800-678-1595
11:00 am to 4:00 pm
Monday - Friday for
testing information, resources and referrals

Subscribe to Free Email Alerts!

Click here to learn more
magnifying glass Advanced Search
Search Tips
Home » HIV/AIDS Program » Literature bibliographies » March - April 2003
HIV/AIDS Program
Bibliographies for March - April 2003
Overviews/Reviews

1. Centers for Disease Control and Prevention. Advancing HIV Prevention: New Strategies for a Changing Epidemic-United States, 2003 MMWR, April 18, 2003; 52(15): 329-332. Available on line at: www.cdc.gov/mmwr/preview/mmwrhtml/mm5215a1.htm. Accessed April 17, 2003
2. Nakashima AK and Fleming PL. HIV/AIDS Surveillance in the United States, 1981-2001. JAIDS, Feb. 1, 2003; 32(Suppl 1):S68-S85.
3. Brown L, Macintyre K and Trujillo L. Interventions to Reduce HIV/AIDS Stigma: What Have We Learned? AIDS Education & Prevention, Feb. 2003; 15(1): 49-69.
4. Knodel, J and VanLandingham, M. The Impact of the AIDS Epidemic on Older Persons. AIDS, 2002; 16(3): S77-S83.
Living with HIV

5 Valente, S. Depression and HIV Disease. Journal of the Association of Nurses in AIDS Care, March/April 2003; 14(2): 41-51.
6. Serovich J, Mosack K. Reasons for HIV Disclosure or Nondisclosure to Casual Sexual Partners. AIDS Education and Prevention, 2003; 15(1): 70-80.
7. Rokach A. Coping With Loneliness and HIV. Focus. February 2003; 18(3): 1-3.
8. Siegel K, Lekas H. AIDS as a Chronic Illness: Psycosocial Implications. AIDS, 2002; 16(4): S69-S76.
9. Spira R, Lert F. Social Health Inequalities During the Course of Chronic HIV Disease in the Era of Highly Active Antiretroviral Therapy. AIDS, 2003; 17(3): 283-290.
10. Hayes C, Elliot E, Krales E, et al. Food and Water Safety for Persons Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases, 2003; 36(2): S106-9.
11. Nerad J, Romeyn M, Silverman E, et. al. General Nutrition Management in Patients Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases, 2003; 36(2): S52-62.
MSM

12. Woods W, Binson D, Pollack L, et. al. Public Policy Regulating Private and Public Space in Gay Bathhouses. JAIDS, April 1, 2003; 32(4): 417-423.
13. Journal of Acquired Immune Deficiency Syndromes. HIV Treatments Optimism Among Gay Men: An International Perspective. JAIDS, April 15, 2003; 32(5): 545-550.
14. Tikkanen R, Ross M. Technological Tearoom Trade: Characteristics of Swedish Men Visiting Gay Internet Chat Rooms. AIDS Education and Prevention, 2003; 15(2): 122-132.
15. Weber A, Craib K, Chan K, et. al. Determinants of HIV Serconversion in an era of Increasing HIV Infection Among Yound Gay and Bisexual Men. AIDS, 2003; 17(5): 774-777.
Pediatric

16. Moss W, Clements J, Halsey N. Immunization of Children at Risk of Infection with Human Immunodeficiency Virus. Bulletin of the World Health Organization. 2003; 81(1): 61-70.
17. Centers for Disease Control and Prevention. Pregnancy in Perinatally HIV-Infected Adolescents and Young Adults—Puerto Rico, 2002. MMWR, February 28, 2003; 52(8): 149-151. Available on line at: www.cdc.gov/mmwr/preview/mmwrhtml/mm5208a1.htm. Accessed February 28, 2003.
18. Journal of Acquired Immune Deficiency Syndromes. Exposure to Antiretroviral Therapy in Utero or Early Life: The Health of Uninfected Children Born to HIV-Infected Women. JAIDS-European Collaborative Study, April 1, 2003; 32(4): 380-387.
Harm Reduction/Drug Use

19. Strauss S, DesJarlais D, Astone J, et. al. On-Site HIV Testing in Residential Drug Treatment Units: Results of a Nationwide Survey. Public Health Reports. January-February 2003; 118: 37-43.
20. Evans J, Hahn J, Shafer K, et. al. Gender Differences in Sexual and Injection Risk Behavior Among Active Young Injection Drug Users in San Francisco (the UFO Study). Journal of Urban Health: Bulletin of the New York Academy of Medicine. March 2003; 80(1): 137-146.
21. Takakashi T, Merrill J, Boyko E, et. al. Type and Location of Injection Drug Use-Related Soft Tissue Injections Predict Hospitalization. Journal of Urban Health: Bulletin of the New York Academy of Medicine. March 2003; 80(1): 127-136.
22. Roy E, Haley N, Leclerc P, Cedras L, et. al. Drug Injection Among Street Youths in Montreal: Predictors of Initiation. Journal of Urban Health: Bulletin of the New York Academy of Medicine. March 2003; 80(1): 92-105.
23. Kakko J, Svanborg K, Kreek M, et. al. 1-Year Retention and Social Function After Buprenorhhine-Assisted Relapse Prevention Treatment for Heroin Dependence in Sweden: A Randomised, Placebo-Controlled Trial. The Lancet. February 22, 2003; 361: 662-668.
24. Law F, Nutt D. Maintenance Buprenorphine for Opioid Users. The Lancet. February 22, 2003; 361: 634-635.
25. Ritter A, Fry C, Swan A. The Ethics of Reimbursing Injecting Drug Users for Public Health Research Interviews: What Price Are We Prepared to Pay. International Journal of Drug Policy. 2003; 14: 1-3.
26. Strathdee S. Sexual HIV Transmission In The Context Of Injection Drug Use: Implications For Interventions. International Journal o f Drug Policy; 14: 79-81.
27. Vickerman P, Watts C. Injecting Drug Use And The Sexual Transmission Of HIV: Simple Model Insights. International Journal of Drug Policy. 2003; 14: 89-93.
28. Editorial. Supervised Injection Rooms-Prospects And Limitations. International Journal of Drug Policy. 2002; 13: 449-451.
29. Degenhardt L, Topp L. 'Crystal Meth' Use Among Polydrug Users In Sydney's Dance Party Subculture: Characteristics, Use Patterns And Associated Harms. International Journal of Drug Policy. 2003; 14: 17-24.
Prevention/Education

30. Perdue T, Hagan H, Thiede H, et. al. Depression And HIV Risk Behavior Among Seattle-Area Injection Drug Users And Young Men Who Have Sex With Men. AIDS Education and Prevention. 2003; 15(1): 81-92.
31. Kamali A, Quigley M, Nakiyingi J, et. al. Syndromic Management Of Sexully-Transmitted Infections And Behaviour Change Interventions On Transmission Of HIV-1 In Rural Uganda: A Community Randomised Trial. The Lancet. February 22, 2003; 361: 645-652.
32. Law F, Nutt D. Evaluating Interventions For HIV Prevention In Africa. The Lancet. February 22, 2003; 361: 633-635.
33. Sterk C, Theall K, Elifson K. Effectiveness Of A Risk Reduction Intervention Among African American Women Who Use Crack Cocaine. AIDS Education and Prevention. 2003; 15(1): 15-32.
34. Baker S, Beadnell B, Stoner S, et. al. Skills Training Versus Health Education To Prevent STDs/HIV In Heterosexual Women: A Randomized Controlled Trial Utilizing Biological Outcomes. AIDS Education and Prevention. 2003; 15(1): 1-14.
35. Paul J. Coerced Childhood Sexual Episodes And Adult HIV Prevention. Focus. April 2003; 18(5): 1-8.
36. Wilson B, Miller R. Examining Strategies For Culturally Grounded HIV Prevention: A Review. AIDS Education and Prevention. 2003; 15(2): 184-202.
STDs

37. Sellors J, Karwalajtys T, Kaczorowski J, et. al. Incidence, Clearance And Predictors Of Human Papillomavirus Infection In Women. Canadian Medical Association. February 18,2003; 168(4): 421-5.
38. Mills J, Mindel A. Genital Herpes Simplex Infections: Some Therapeutic Dilemmas. American Sexually Transmitted Diseases Association. 2002; 30(3): 232-233.
39. Lee J, Jennings J, Ellen J. Discordant Sexual Partnering-A Study of High-Risk Adolescents in San Francisco. Sexually Transmitted Diseases. March 2003; 30(1): 234-240.
40. Becher J, Aral S. Gap Length: An Important Factor In Sexually Transmitted Disease Transmission. Sexually Transmitted Diseases. March 2003; 30(3): 221-225.
41. Gilbert L, Alexander L, Grosshans J, et. al. Answering Frequently Asked Questions About HPV. Sexually Transmitted Diseases. March 2003; 193-194.
42. Beyrer C. Hidden Epidemic of Sexually Transmitted Diseases in China-Crisis and Opportunity. JAMA. March 12, 2003; 289(10): 1303-1305.
43. Turner K, McFarland W, Kellogg T, et. al. Incidence and Prevalence of Herpes Simplex Virus Type 2 Infection in Persons Seeking Repeat HIV Counseling and Testing. Sexually Transmitted Diseases. April 2003; 30(4): 331-334.
44. Piketty C, Darragh T, Da Costa M, et. al. High Prevalence of Anal Human Papillomavirus Infection and Anal Cancer Precursors Among HIV-Infected Persons in the Absence of Anal Intercourse. Annals of Internal Medicine. March 18, 2003; 138(6): 453-459.
45. Morrow R, Krantz E, Wald A. Time Course of Seroconversion by HerpeSelect ELISA After Acquisition of Genital Herpes Simplex Virus Type 1 (HSV-1) or HSV-2. Sexually Transmitted Diseases. April 2003; 30(4): 310-314.
Counseling, Testing, and Partner Notification

46. Branson B, Del Rio C, Larrabee S, et. al. Rapid Fingerstick Testing: A New Era in HIV Diagnostics. AIDS Clinical Care. March 2003; 15(3): 19-24.
47. Wright K. Rapid Test Time. POZ. February/March 2003; 34-37.
48. Spielberg F, Branson B, Godbaum G, et. al. Overcoming Barriers to HIV Testing: Preferences for New Strategies Among Clients of a Needle Exchange, a Sexually Transmitted Disease Clinic, and Sex Venues for Men Who Have Sex with Men. JAIDS. March 1, 2003; 32(3): 318-327.
Antiretroviral Treatment

49. Kuritzkes D, Currier J. Cardiovascular Risk Factors and Antiretroviral Therapy. The New England Journal of Medicine. February 20, 2003; 348(8): 679-680.
50.

Bozzette S, Ake C, Tam H, et. al. Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection. The New England Journal of Medicine. February 20, 2003; 348(8): 702-710.
51.

Sabine C. The Changing Clinical Epidemiology of AIDS in the Highly Active Antiretroviral Therapy Era. AIDS. 2002; 16(4): S61-S68.
52.

Youle M. Strategies of HIV Management-When to Start. AIDS. 2002; 16(4): S145-S149.
53.

Gulick R, Staszewski S. New Drugs for HIV Therapy. AIDS. 2002; 16(4): S135-S144.
54.

Moore A, Kirk O, Johnson A, et. al. Virologic, Immunologic, and Clinical Response to Highly Active Antiretroviral Therapy: the Gender Issue Revisited. JAIDS Journal of Acquired Immune Deficiency Syndromes. April 1, 2003; 32(4): 452-461.
55.

Barroso P, Schechter M, Gupta P, et. al. Adherence to Antiretroviral Therapy and Persistence of HIV RNA in Semen. JAIDS Journal of Acquired Immune Deficiency Syndromes. April 1, 2003; 32(4): 435-440.
56.

Dilorio C, Resnicow K, McDonnell M, et. al. Using Motivational Interviewing to Promote Adherence to Antiretroviral Medications: A Pilot Study. Journal of the Association for Nurses in AIDS Care. March/April 1, 2003; 14(2): 52-62.
57.

Lane C, Neaton J. When to Start Therapy for HIV Infection: A Swinging Pendulum in Search of Data. Annals of Internal Medicine. April 15, 2003; 138(8): 680-681.
58. Lampe F, Johnson M, Lipman M, et. al. Viral Breakthrough After Suppression With Highly Active Antiretroviral Therapy: Experience From 233 Individuals With Viral Loads of Less than 50 Copies/ML Followed for Up to 4 Years. AIDS. 2003; 17(5): 768-770.
Etiology, Pathology

59. Coombs R, Reichelderfer P, Landay A. Recent Observations on HIV Type-1 Infection in the Genital Tract of Men and Women. AIDS. 2003; 17(4): 455-480.
60. Koelsch K, Smith D, Little S, et. al. Clade B HIV-1 Superinfection with Wild-Type Virus After Primary Infection with Drug-Resistant Clade B Virus. AIDS. 2003; 17(7): F11-F16.
61. Chen A, Boulton I, Pongoski J, et. al. Induction of HIV-1 Long Terminal Repeat-Mediated Transcription by Neisseria Gonorrhoeae. AIDS. 2003; 17(4): 625-628.
Miscellaneous

62. Hamers F, Downs A. HIV in Central and Eastern Europe. The Lancet. March22, 2003; 361: 1035-1044.
63.

Stirn A. Body Piercing: Medical Consequences and Psychological Motivations. The Lancet. April 5, 2003; 361: 1205-1215.
64.

Brewer D, Brody S, Drucker E, et. al. Mounting Anomalies in the Epidemiology of HIV in Africa: Cry the Beloved Paradigm. International Journal of STD & AIDS. March 2003; 14: 144-147.
65.

Gisselquist D, Potterat J, Brody S, et. al. Let it be Sexual: How Health Care Transmission of AIDS I Africa was Ignored. International Journal of STD & AIDS. March 2003; 14: 148-161.
66.

Gisselquist D, Potterat J. Heterosexual Transmission of HIV in Africa: An Empiric Estimate. International Journal of STD & AIDS. March 2003; 14: 162-173.
67.

Gerberding J. Occupational Exposure to HIV in Health Care Settings. The New England Journal of Medicine. February 27, 2003; 348(9): 826-833.
68.

Busch M, Kleinman S, Nemo G. Current and Emerging Infectious Risks of Blood Transfusions. JAMA. February 26, 2003; 289(8): 959-962.
69. Patel D, Gillespie B, Foxman B. Sexual Behavior of Older Women. Sexually Transmitted Diseases. March 2003; 30(3): 216-220.

Updated: Monday, February 13, 2006 at 10:27 AM

All information is general in nature and is not intended to be used as a substitute for appropriate professional advice. For more information please call (206) 296-4600 (voice) or TTY Relay: 711. Mailing address: ATTN: Communications Team, Public Health - Seattle & King County, 401 5th Ave., Suite 1300, Seattle, WA 98104 or click here to email us.

King County | News | Services | Comments | Search

Links to external sites do not constitute endorsements by King County.
By visiting this and other King County web pages, you expressly agree to be bound by terms
and conditions of the site. The details.